Synapsoft logo
AI Insights from Disclosures
Searching...
Peptron, Inc. 087010
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Peptron, Inc. designs and manufactures sustained-release smart pharmaceuticals and develops new peptide drugs, based on its core technologies in peptide engineering and sustained drug release, and has successfully built GMP mass-production facilities capable of implementing its sustained-release pharmaceutical platform technology, thereby securing production capacity for both clinical trials and commercialized products. Based on this, the company aims to develop excellent pharmaceuticals that combine innovative new drugs with sustained-release technology.
Representative Director Choi Hoil
Founded November 21, 1997
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 16011-0067234
Business number 314-81-20409
Phone Number 042-360-8880
Fax Number 042-360-8888
Company Address 37-24 Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant